544220 CTLLAB

Clinitech Laboratory Share Price

₹79.00 +9.2 (13.18%)

21 Nov, 2024 14:04

SIP TrendupStart SIP in CTLLAB

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 2.6%
  • Over 3 Month -11.73%
SIP Lightning

Smart Investing Starts Here Start SIP with Clinitech Laboratory for Steady Growth!

Invest Now

Clinitech Laboratory Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Clinitech Laboratory Financials

Clinitech Laboratory Technicals

EMA & SMA

Current Price
₹79.00
+ 9.2 (13.18%)
pointer
  • stock-down_img
  • Bullish Moving Average 7
  • stock-up_img
  • Bearish Moving Average 4
  • 20 Day
  • ₹78.39
  • 50 Day
  • ₹84.03
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

70.08 Pivot Speed
  • R3 81.27
  • R2 77.63
  • R1 73.72
  • S1 66.17
  • S2 62.53
  • S3 58.62

What's your outlook on Clinitech Laboratory?

You can only vote for once

Clinitech Laboratory Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-13 Half Yearly Results

Clinitech Laboratory F&O

Clinitech Laboratory Shareholding Pattern

No data available.

About Clinitech Laboratory

  • NSE Symbol
  • CTLLAB
  • BSE Symbol
  • 544220
  • ISIN
  • INE0QMR01015

Similar Stocks to Clinitech Laboratory

Clinitech Laboratory FAQs

Clinitech Laboratory share price is ₹79 As on 21 November, 2024 | 13:50

The Market Cap of Clinitech Laboratory is ₹18 Cr As on 21 November, 2024 | 13:50

The P/E ratio of Clinitech Laboratory is As on 21 November, 2024 | 13:50

The PB ratio of Clinitech Laboratory is 7.6 As on 21 November, 2024 | 13:50

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23